retatrutide release FDA Approval Status 2026: Everything We Know So Far How Does Retatrutide Work? Triple

This often leads to a significant decrease in food consumption

What is Retatrutide and how does it differ from Semaglutide and Tirzepatide

The Efficacy Gap: Oral vs Injectable Injectable tirzepatide (Zepbound), a dual GLP-1 and GIP receptor agonist, produced weight reductions of between 16% and 22.5% over 72 weeks in the SURMOUNT trials

Observations in those treated with GLP-1RA subsequently confirmed weight loss in people with T2D, and later obesity (1)

[DOI] [PMC free article] [PubMed] [Google Scholar] 224.Thyssen S, Arany E, Hill DJ

Non-gastrointestinal side effects are also common, such as headache, dehydration, and injection site reactions